Periscope Capital’s Longevity Acquisition Corporation Ordinary Shares LOAC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-206,100
Closed -$2.17M 272
2020
Q1
$2.17M Hold
206,100
0.26% 129
2019
Q4
$2.15M Buy
206,100
+25,000
+14% +$260K 0.26% 127
2019
Q3
$1.88M Sell
181,100
-200
-0.1% -$2.04K 0.24% 130
2019
Q2
$1.84M Hold
181,300
0.26% 115
2019
Q1
$1.81M Hold
181,300
0.31% 102
2018
Q4
$1.81M Buy
+181,300
New +$1.78M 0.34% 98

Other funds holding LOAC

Periscope Capital's LOAC Position: Q2 2020 in Review

Periscope Capital sold out of Longevity Acquisition Corporation Ordinary Shares (LOAC) in Q2 2020, closing a stake of 206,100 shares — an estimated $2.17M sold.

Periscope Capital first reported a position in LOAC in Q4 2018 and held it in 6 quarters. The position peaked at $2.17M in Q1 2020. 10 funds tracked by Wall St. Rank hold LOAC as of Q2 2020.

  • Periscope Capital reported no remaining Longevity Acquisition Corporation Ordinary Shares position as of Q2 2020 after selling out during the quarter.
  • Periscope Capital sold 206,100 Longevity Acquisition Corporation Ordinary Shares shares in Q2 2020, an estimated $2.17M.
  • Periscope Capital first reported a position in Longevity Acquisition Corporation Ordinary Shares in Q4 2018 and held it in 6 quarters.
  • Periscope Capital's Longevity Acquisition Corporation Ordinary Shares position peaked at $2.17M in Q1 2020.
  • 10 funds tracked by Wall St. Rank held Longevity Acquisition Corporation Ordinary Shares as of Q2 2020.

Based on Periscope Capital's 13F filing for Q2 2020, filed 11 Aug 2020.